Global Chip-based Oligonucleotide Synthesis Market Growth (Status and Outlook) 2024-2030

Global Chip-based Oligonucleotide Synthesis Market Growth (Status and Outlook) 2024-2030

Product Code:1237242

Published Date: Nov 12,2024

Pages: 87

Region: Global

Category: New Technology

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Chip-based Oligonucleotide Synthesis market size is projected to grow from US$ 40.1 million in 2024 to US$ 149 million in 2030; it is expected to grow at a CAGR of 24.5% from 2024 to 2030.

Chip-based oligonucleotide synthesis is a high-throughput, cost-effective method utilizing microarray chips to mass-produce short DNA or RNA fragments. Compared to traditional synthesis methods, this technology offers faster speed, higher precision, and greater flexibility, making it especially suitable for fields like gene editing, synthetic biology, and genome sequencing. By enabling parallel synthesis, researchers can simultaneously produce thousands to millions of different oligonucleotide sequences on a single chip, significantly improving experimental efficiency and data output, thereby accelerating research and applications in the life sciences.

United States market for Chip-based Oligonucleotide Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Chip-based Oligonucleotide Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Chip-based Oligonucleotide Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Chip-based Oligonucleotide Synthesis players cover Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “Chip-based Oligonucleotide Synthesis Industry Forecast” looks at past sales and reviews total world Chip-based Oligonucleotide Synthesis sales in 2023, providing a comprehensive analysis by region and market sector of projected Chip-based Oligonucleotide Synthesis sales for 2024 through 2030. With Chip-based Oligonucleotide Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chip-based Oligonucleotide Synthesis industry.

This Insight Report provides a comprehensive analysis of the global Chip-based Oligonucleotide Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chip-based Oligonucleotide Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chip-based Oligonucleotide Synthesis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chip-based Oligonucleotide Synthesis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chip-based Oligonucleotide Synthesis.

This report presents a comprehensive overview, market shares, and growth opportunities of Chip-based Oligonucleotide Synthesis market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Photochemical Method
    Electrochemical Method
    Inkjet Printing Method

Segmentation by Application:
    Scientific Research
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Photochemical Method
    Electrochemical Method
    Inkjet Printing Method

Segmentation by Application:
    Scientific Research
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Thermo Fisher
    GenScript
    LC Sciences
    Twist Bioscience
    Agilent Technologies
    Evonetix
    Dynegene Technologies
    LC-Bio Technologies
    Atantares
    BGI Genomics